The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 20,701–20,800 of 31,469
Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women
Crispo, A., Montella, M., Buono, G., Grimaldi, M., D’Aiuto, M., Capasso, I., Esposito, E., Amore, A., Nocerino, F., Augustin, L. S. A., et al. (2016) · Current Research in Translational Medicine · doi:10.1016/j.retram.2016.01.004 · Cited by 9
Étiologie et physiopathologie du diabète de type 2
Rigalleau, V., Lang, J., & Gin, H. (2007) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(07)46586-6 · Cited by 10
Lipin 1 Gene Polymorphisms in Polycystic Ovary Syndrome
Mlinar, B., Ferk, P., Pfeifer, M., et al. (2011) · Hormone and Metabolic Research · doi:10.1055/s-0031-1273761 · Cited by 10
Erdoğan, E., Akkaya, M., Bacaksız, A., Taşal, A., Turfan, M., Kul, Ş., Sönmez, O., Vatankulu, M. A., Ertaş, G., Batmaz, G., et al. (2013) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2013.196 · Cited by 11
Skin pigmentation is inversely associated with insulin resistance in healthy Japanese women
Nagata, C., Konish, K., Tamura, T., et al. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.04.001 · Cited by 10
Utku, İ. K., Okuturlar, Y., Demir, E. Y., Harmankaya, Ö., Açıksarı, G., Uygun, T., Kural, A., Ozkan, H., Mert, M., & Kumbasar, A. (2015) · PubMed Central · Cited by 10
Prevalence of insulin resistance in schizophrenia in HUKM.
Fairuz, A. R., Maniam, T., & Khalid, B. A. K. (2007) · PubMed · Cited by 10
Mainasara, A., Isa, S. A., Dandare, A., et al. (2016) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-160060 · Cited by 10
Vaverkova, H., Karásek, D., Novotný, D., Halenka, M., Orság, J., & Slavík, L. (2015) · Physiological Research · doi:10.33549/physiolres.933198 · Cited by 9
Insulin resistance and metabolic syndrome in elderly women living in nursing homes.
Nasution, I. R., Setiati, S., Trisnohadi, H. B., & Oemardi, M. (2006) · PubMed · Cited by 9
Halici, I., Palabıyık, Ş. S., Guducu‐Tufekci, F., Bilgin, A. Ö., & Çayır, A. (2016) · Pediatrics International · doi:10.1111/ped.12989 · Cited by 10
Sedaka, N. M., Olsen, C. H., Yannai, L., Stutzman, W. E., Krause, A. J., Sherafat‐Kazemzadeh, R., Condarco, T. A., Brady, S. M., Demidowich, A. P., Reynolds, J. C., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.145 · Cited by 10
Brusik, M., Štrbová, Z., Petrášová, D., Pobeha, P., Kuklisova, Z., Tkáčová, R., & Joppa, P. (2016) · Physiological Research · doi:10.33549/physiolres.933277 · Cited by 10
Derosa, G., Maffioli, P., D’Avino, M., et al. (2016) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12235 · Cited by 10
Irisin and Myostatin Levels in Patients with Graves' Disease
Yalçın, M. M., Aktürk, M., Tohma, Y., Cerit, E. T., Altınova, A. E., Arslan, E., Yetkin, İ., & Törüner, F. B. (2016) · Archives of Medical Research · doi:10.1016/j.arcmed.2016.11.002 · Cited by 10
The impact of adiponectin levels on biomarkers of inflammation among adolescents with obesity
Vicente, S. E. D. C. F., Corgosinho, F. C., Campos, R. M. D. S., Masquio, D. C. L., Silva, L. O. E., Kravchychyn, A. C. P., Sanches, P. D. L., de Piano, A., Oyama, L. M., Tock, L., et al. (2017) · Obesity Medicine · doi:10.1016/j.obmed.2016.12.002 · Cited by 10
Seven cases with Williams-Beuren syndrome: endocrine evaluation and long-term follow-up
Güven, A. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0039 · Cited by 10
Marotta, A. M., Borel, J., Galerneau, L.-M., Tamisier, R., Bonsignore, M. R., & Pépin, J. (2017) · Respiration · doi:10.1159/000454988 · Cited by 10
Nishimura, R., Sano, H., Onda, Y., Tsujino, D., Ando, K., Ebara, F., Matsudaira, T., Ishikawa, S., Sakamoto, T., Tajima, N., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12637 · Cited by 10
Absence of association between gallstone and coronary artery calcification
Kwon, C. H., Kang, J. G., Lee, H., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.01.035 · Cited by 10
Parrinello, C. M., Hua, S., Carnethon, M. R., Gallo, L. C., Hudson, B. I., Goldberg, R. B., Delamater, A. M., Kaplan, R. C., & Isasi, C. R. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.019 · Cited by 10
Ghaffar, S., Afridi, S. K., Aftab, M. F., Murtaza, M., Hafizur, R. M., Sara, S., Begum, S., & Waraich, R. S. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3835 · Cited by 10
Wilms, B., Ernst, B., Thurnheer, M., Spengler, C. M., & Schultes, B. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-100102 · Cited by 10
Wang, J. H., Hong, Z., Wu, L. J., Ding, B., Bi, Y., Gu, Z., & Li, W. (2017) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2016-0660 · Cited by 10
Kuipers, A. L., Zmuda, J. M., Carr, J. J., Terry, J. G., Nair, S., Cvejkus, R., Bunker, C. H., Patrick, A. L., Wassel, C. L., & Miljkovic, I. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.030 · Cited by 10
Impact of Glucose Metabolism Disorders on IGF-1 Levels in Patients with Acromegaly
Doğanşen, S. Ç., Yalın, G. Y., Tanrıkulu, S., & Yarman, S. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0594-2404 · Cited by 11
Rowe, C. W., Haider, A. S., Viswanathan, D., Jones, M. A., Attia, J., Wynne, K., & Acharya, S. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.06.022 · Cited by 10
Rajendran, J., Srinivasan, A. R., Gopal, N., & Ramasamy, R. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.07.010 · Cited by 10
Circulating C3 and glucose metabolism abnormalities in patients with OSAHS
Lü, X., Wang, X., Xu, T., Feng, Y., Wang, Y., Cai, Z., Cao, B., & Li, T. (2017) · Sleep And Breathing · doi:10.1007/s11325-017-1564-8 · Cited by 11
Hall, B., Żebrowska, A., Kamiński, T., Stanula, A., & Robins, A. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-110482 · Cited by 11
Interleukin-18 polymorphism as an inflammatory index in metabolic syndrome: A preliminary study
Fatima, S. S., Jamil, Z., Abidi, S. H., Nadeem, D. M., Bashir, Z., & Ansari, A. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i6.304 · Cited by 10
Higher Levels of Cystatin C in HIV / AIDS Patients with Metabolic Syndrome
Dragović, G., Srdić, D., Al-Musalhi, K., Soldatović, I., Kušić, J., Jevtović, D., & Nair, D. R. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12919 · Cited by 10
Borges, C. C., Penna‐de‐Carvalho, A., Medeiros, J. L., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.10.002 · Cited by 10
Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes
Lee, J.-Y., Cho, Y., Lee, M., Lee, Y., Lee, B., Kang, E. S., & Cha, B.-S. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.11.005 · Cited by 10
Bouziana, S. D., Τζιόμαλος, Κ., Goulas, A., Vyzantiadis, T., Panderi, A., & Hatzitolios, A. I. (2017) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.10.038 · Cited by 10
Zazai, R., Wilms, B., Ernst, B., Keppler, R., Thurnheer, M., Schmid, S. M., & Schultes, B. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-121568 · Cited by 10
Archontogeorgis, K., Παπάνας, Ν., Nena, E., Tzouvelekis, A., Tsigalou, C., Voulgaris, A., Xanthoudaki, M., Mouemin, T., Froudarakis, Μ. E., & Steiropoulos, P. (2017) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401711010159 · Cited by 10
Dugas, C., Kearney, M., Mercier, R., Perron, J., Tchernof, A., Marc, I., Weisnagel, S. J., & Robitaille, J. (2018) · Early Human Development · doi:10.1016/j.earlhumdev.2018.02.004 · Cited by 10
Dietary Behaviors and Glucose Metabolism in Young Adults at Risk for Type 2 Diabetes
Cha, E., Paul, S., Braxter, B., Umpierrez, G. E., & Faulkner, M. S. (2018) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721718756057 · Cited by 11
Insulin sensitivity is reduced in children with high body-fat regardless of BMI
Fairchild, T. J., Klakk, H., Heidemann, M., Grøntved, A., & Wedderkopp, N. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0043-z · Cited by 10
Agrawal, R., Nath, V., Kumar, H., & Kumar, V. (2018) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2018.1436560 · Cited by 10
The assessment of thyroid autoantibody levels in euthyroid polycystic ovary syndrome patients
Hepşen, S., Karaköse, M., Çakal, E., Öztekin, S., Ünsal, İ. Ö., Akhanlı, P., Uçan, B., & Özbek, M. (2018) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.2018.0001 · Cited by 10
Barbonetti, A., D’Andrea, S., Samavat, J., Martorella, A., Felzani, G., Francavilla, S., Luconi, M., & Francavilla, F. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0897-x · Cited by 10
González-Saldivar, G., Rodríguez‐Gutiérrez, R., Treviño‐Alvarez, A. M., Gómez‐Flores, M., Montes‐Villarreal, J., Álvarez‐Villalobos, N. A., Elizondo-Plazas, A., Salcido‐Montenegro, A., Ocampo‐Candiani, J., & González‐González, J. G. (2018) · Dermato-Endocrinology · doi:10.1080/19381980.2018.1471958 · Cited by 11
Health behaviour changes in partners of women with recent gestational diabetes: a phase IIa trial
Brazeau, A., Meltzer, S. J., Pace, R., Garfield, N., Godbout, A., Meissner, L., Rahme, E., Costa, D. D., & Dasgupta, K. (2018) · BMC Public Health · doi:10.1186/s12889-018-5490-x · Cited by 10
Loss of Cardio-Protective Effects at the CDH13 Locus Due to Gene-Sleep Interaction: The BCAMS Study
Li, G., Feng, D., Wang, Y., Fu, J., Han, L., Li, L., Grant, S. F. A., Li, M., Li, M., & Gao, S. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.05.033 · Cited by 10
Underperforming doctors in general practice: a survey of referrals to UK Deaneries.
Bahrami, J., & Evans, A. (2001) · Europe PMC (PubMed Central) · Cited by 10
Gagliano‐Jucá, T., Burak, M. F., Pencina, K. M., Li, Z., Edwards, R. R., Travison, T. G., & Basaria, S. S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01068 · Cited by 11
Zhang, X., Qiu, K., Wang, L., Xu, D., & Yin, J. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800637 · Cited by 10
El-Kharashi, O. A., El-Waseef, D. A. E.-D. A., Nabih, E. S., & Mohamed, D. I. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.032 · Cited by 10
Aydoğan, Y., Altay, M., Ünsal, O., Kaplanoğlu, V., Çağır, Y., Yıldız, C., Beyan, E., & Ramadan, S. U. (2018) · Endocrine · doi:10.1007/s12020-018-1701-6 · Cited by 9
Serbis, A., Giapros, V. I., Challa, A. S., Chaliasos, N., & Siomou, E. C. (2018) · Clinical Endocrinology · doi:10.1111/cen.13859 · Cited by 10
Serum betatrophin levels are reduced in patients with full-blown polycystic ovary syndrome
Haydardedeoğlu, F. E., Bağır, G. Ş., Haydardedeoğlu, B., Bozkırlı, E., Bakıner, O., Metin, K., & Ertörer, M. E. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1519791 · Cited by 10
Liu, T., Wang, Q., Huang, W., Tan, J., Liu, D., Pei, T., Li, X., & Zhou, G. (2018) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.10.001 · Cited by 11
Swimming intervention alleviates insulin resistance and chronic inflammation in metabolic syndrome
Tan, J., & Guo, L. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6900 · Cited by 10
Cuñarro, J., Buqué, X., Casado, S., Lugilde, J., Vidal, A., Mora, A., Sabio, G., Nogueiras, R., Aspichueta, P., Diéguez, C., et al. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801096 · Cited by 11
Association between rosacea severity and relative muscle mass: A cross‐sectional study
Nam, J., Yang, J., Park, J., Seo, J. H., Chang, Y., Ryu, S., & Kim, W. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14689 · Cited by 10
Verrusio, W., Magro, V. M., Renzi, A., Casciaro, B., Andreozzi, P., & Cacciafesta, M. (2018) · Aging Clinical and Experimental Research · doi:10.1007/s40520-018-1071-1 · Cited by 10
Pegington, M., Evans, D. G., Howell, A., et al. (2018) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000493 · Cited by 10
Skin autofluorescence in children with and without obesity
Lentferink, Y. E., van Teeseling, L., Knibbe, C. A. J., & van der Vorst, M. M. J. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0237 · Cited by 10
Lajeunesse‐Trempe, F., Dufour, R., du Souich, P., et al. (2018) · Annals of Human Biology · doi:10.1080/03014460.2018.1562568 · Cited by 10
Haljas, K., Hakaste, L., Lahti, J. M. T., Isomaa, B., Groop, L., Tuomilehto, J., & Räikkönen, K. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1564357 · Cited by 11
Tarp, J., Bugge, A., Møller, N. C., Klakk, H., Rexen, C. T., Grøntved, A., & Wedderkopp, N. (2019) · Journal of Physical Activity and Health · doi:10.1123/jpah.2017-0678 · Cited by 9
Motiani, P., Teuho, J., Saari, T., Virtanen, K. A., Honkala, S. M., Middelbeek, R. J. W., Goodyear, L. J., Eskola, O., Andersson, J., Löyttyniemi, E., et al. (2019) · Obesity Science & Practice · doi:10.1002/osp4.330 · Cited by 10
Noda, M. F., Delgado-Herrera, D. C., Cabrera‐Rode, E., et al. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.02.011 · Cited by 10
Cardiovascular Risk Assessment in Pediatric Liver Transplant Patients
Dégi, A. A., Bárczi, A., Szabó, D., Kis, É., Reusz, G., & Dezsőfi, A. (2019) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002196 · Cited by 10
Sánchez-Ferrer, M. L., Prieto‐Sánchez, M. T., Corbalán‐Biyang, S., Mendiola, J., Adoamnei, E., Peñalver, A. I. H., Carmona‐Barnosi, A., Salido-Fiérrez, E., & Torres-Cantero, A. M. (2019) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2019.01.013 · Cited by 10
Folate and Vitamin B12 in Morbid Obesity: The Influence of Folate on Anti-Atherogenic Lipid Profile
Daviddi, G., Ricci, M. A., VUONO, S. D., Gentili, A., Boni, M., & Lupattelli, G. (2019) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000538 · Cited by 10
Aksoy, E. K., Göktaş, Z., Albuz, Ö., AKPINAR, M. Y., Öztürk, D., Buluş, H., & Uzman, M. (2019) · Journal of Laboratory Medicine · doi:10.1515/labmed-2018-0181 · Cited by 10
Predictors of Net Acid Excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study
Brown, L. C., Luciano, A., Pendergast, J., Khairallah, P., Anderson, C. A. M., Sondheimer, J., Hamm, L. L., Ricardo, A. C., Rao, P. S., Rahman, M., et al. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.12.043 · Cited by 10
Hwang, Y., Kim, S. W., Hur, K. Y., Soo, B., Kim, I. J., Park, T. S., Baik, S. H., Yoon, K., Lee, K. W., Lee, I. K., et al. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e117 · Cited by 10
Vihonen, H., Kuisma, M., Salo, A., Ångerman, S., Pietiläinen, K. H., & Nurmi, J. O. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214209 · Cited by 10
Lewandowski, K. C., Płusajska, J., Horzelski, W., & Lewiñski, A. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0896-4144 · Cited by 10
Proinsulin is sensitive to reflect glucose intolerance
Nakamura, A., Miyoshi, H., Ukawa, S., Nakamura, K., Nakagawa, T., Terauchi, Y., Tamakoshi, A., & Atsumi, T. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13106 · Cited by 9
Duong, T. V., Shih, C., Wong, T.-C., Chen, H.-H., Chen, T.-H., Hsu, Y., Peng, S., Kuo, K., Liu, H.-C., Lin, E.-T., et al. (2019) · BioMed Research International · doi:10.1155/2019/1541593 · Cited by 10
Kokkvoll, A. S., Grimsgaard, S., Flægstad, T., Andersen, L. B., Ball, G. D. C., Wilsgaard, T., & Njølstad, I. (2019) · Acta Paediatrica · doi:10.1111/apa.14916 · Cited by 10
Mutavdžin, S., Gopčević, K., Stankovic, S. D., et al. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0027 · Cited by 10
Caamaño, M. D. C., García, O. P., Parás, P., et al. (2019) · Food and Nutrition Bulletin · doi:10.1177/0379572119863558 · Cited by 10
Samaha, M. M., Said, E., & Salem, H. A. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172569 · Cited by 10
Bethancourt, H. J., Kratz, M., & O–Connor, K. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz153 · Cited by 10
Li, J., Xu, S., Liu, Y., Yan, Z., Zhang, F., Lv, Q., & Tong, N. (2019) · Lipids · doi:10.1002/lipd.12182 · Cited by 10
Younan, N., Elattar, S., Youssef, M. F., Rashed, L. A., & Estaphan, S. (2019) · Physiological Reports · doi:10.14814/phy2.14191 · Cited by 10
Lowry, J. E., Tumurbaatar, B., D’Agostino, C., Main, E., Wright, T. J., Dillon, E. L., Saito, T. B., Porter, C. C., Andersen, C. R., Brining, D. L., et al. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519002472 · Cited by 10
Mice experimental model of diabetes mellitus type ii based on high fat diet
Капилевич, Л. В., Zakharova, A. N., Dyakova, E. Y., et al. (2019) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2019-3-53-61 · Cited by 10
Boughanem, H., Cabrera-Mulero, A., Hernández‐Alonso, P., Bandera-Merchán, B., Tinahones, A., Tinahones, F. J., Morcillo, S., & Macías‐González, M. (2019) · Cancers · doi:10.3390/cancers11111629 · Cited by 10
Gyu, C., & Shim, Y. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-51963-7 · Cited by 11
Ashtary‐Larky, D., Kheirollah, A., Bagheri, R., Ghaffari, M. A., Mard, S. A., Hashemi, S. J., Mir, I., & Wong, A. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519002770 · Cited by 12
Tona, F., Boscaro, M., Barbot, M., et al. (2019) · Microvascular Research · doi:10.1016/j.mvr.2019.103940 · Cited by 10
Kang, B.-K., Kim, M., Shin, S., et al. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e298 · Cited by 10
Chang, H. H., Chang, W. H., Chi, M. H., Peng, Y., Huang, C.-C. J., Yang, Y. K., & Chen, P. S. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s226245 · Cited by 10
Li, X., Shen, Y., Zhu, J., et al. (2019) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201900158 · Cited by 10
The effects of age and obesity on postprandial dynamics of serum testosterone levels in men
de Velde, F. V., Reyns, T., Toye, K. R. C., Fiers, T., Kaufman, J., T'Sjoen, G. G., & Lapauw, B. (2019) · Clinical Endocrinology · doi:10.1111/cen.14141 · Cited by 10
Sex Differences in the Risk of Barrett’s Esophagus Associated With the Metabolic Effects of Obesity
Kendall, B. J., Macdonald, G. A., Prins, J. B., et al. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001307 · Cited by 10
Increased urocortin 3 levels are associated with the risk of having type 2 diabetes mellitus
Alarslan, P., Kocabaş, G. Ü., Demir, İ., Güler, A., Bozkaya, G., Aslanıpour, B., & Çalan, M. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13020 · Cited by 8
van Dijk, P. R., Abdulle, A. E., Bulthuis, M. L. C., Perton, F. G., Connelly, M. A., van Goor, H., & Dullaart, R. P. F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010049 · Cited by 10
El-Deen, R. M., Heeba, G. H., Abdellatif, R., & Khalifa, M. M. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12530 · Cited by 11
Liberato, C. B. R., Olegário, N. B. D. C., Fernandes, V. O., et al. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s233667 · Cited by 10
Chien, M., Lee, P., Yu, C., Wei, S. Y., & Shih, T. T. (2020) · Nature and Science of Sleep · doi:10.2147/nss.s232554 · Cited by 10
Montenegro, R. M., Lima, G. E. D. C. P., Fernandes, V. O., Montenegro, A. P. D. R., Ponte, C. M. M., Martins, L. V., Pinheiro, D. P., de Moraes, M. E. A., de Moraes, M. O., & d’Alva, C. B. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00538-y · Cited by 10
Shah, M., Adel, M., Tahsin, B., Guerra, Y., & Fogelfeld, L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231190 · Cited by 7
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
